Our top- and bottom-line projections for full-year 2021 remain bounded by management’s 2021 outlook, and the slight adjustments we’ve made to reflect strong cost containment were largely offset by our incorporation of a rise in the U.S. corporate tax rate starting in 2022.
In the absolute, Quest’s second-quarter results look impressive, with revenue up 40% and operating margin at 21% (compared with 16% in the year-ago period). Nonetheless, Quest’s second quarter demonstrated slower growth than seen in the last three quarters as vaccinations have rolled out across the U.S.
Fortunately, as COVID-19 tests wane, the resumption of growth in non pandemic tests has been strong. This has resulted in mix shift gradually driving quarterly gross margin down to 39% versus 43% in the second half of 2020. Profitability in the second quarter remains significantly higher than Quest’s historical levels.
Company’s Future Outlook
It is expected that the demand for COVID-19 molecular tests will settle into a lower, but ongoing level into 2022, considering the significant level of Americans who have not yet been fully vaccinated and the rise of new, more contagious variants. Management indicated that COVID-19 PCR test volume has recently stabilized and begun to grow slightly as viral spread and hot spots have grown. It is further predicted that the margin erosion as volume further shifts toward non pandemic tests.
Company Profile
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of nearly 2,300 patient service centers, as well as multiple doctors’ offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
(Source: Morningstar)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.